NEW YORK (GenomeWeb News) — Becton Dickinson today said that fiscal second-quarter revenues rose 11 percent as R&D spending decreased 32 percent and profit swelled 57 percent.
 
Total receipts for the three months ended March 31 increased to $1.6 billion from $1.4 billion year over year.
 
BD said revenues from its Diagnostics segment increased 11 percent to $473 million, while Biosciences revenue rose 13 percent to $258.5 million. Revenue from the Medical segment rose 10 percent to $844.1 million.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.